Other
Net Change in Cash
Edwards Lifesciences Net Change in Cash increased by 17.3% to -$492.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 646.7%, from $90.00M to -$492.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
Metric ID:
net_change_in_cashHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $135.00M | $194.00M | -$652.50M | $167.90M | $167.60M | $48.80M | -$479.10M | $103.80M | $171.10M | $366.40M | $81.00M | $429.10M | $2.03B | $90.00M | $141.20M | -$595.20M | -$492.00M |
| QoQ Change | — | +43.7% | -436.3% | +125.7% | -0.2% | -70.9% | <-999% | +121.7% | +64.8% | +114.1% | -77.9% | +429.8% | +372.0% | -95.6% | +56.9% | -521.5% | +17.3% |
| YoY Change | — | — | — | — | +24.1% | -74.8% | +26.6% | -38.2% | +2.1% | +650.8% | -22.0% | +150.8% | +452.8% | +11.1% | -67.1% | -129.4% | -646.7% |
Range-$652.50M – $2.03B
CAGR+38.2%
Avg YoY Growth+26.2%
Median YoY Growth+2.1%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's net change in cash?
- Edwards Lifesciences (EW) reported net change in cash of -$492.00M in Q1 2026.
- How has Edwards Lifesciences's net change in cash changed year-over-year?
- Edwards Lifesciences's net change in cash decreased by 646.7% year-over-year, from $90.00M to -$492.00M.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.